Contract facts
FederalTHYROSEQ GENOMIC TESTING is a federal award for 246-Network Contracting Office 6 (36C246) held by Cytopath Biopsy Lab Inc. Estimated value —. Related solicitation 36C24626Q0049.
Incumbent footprint
Public recordCytopath Biopsy Lab Inc — $5.9M obligated across 72 awards (firm-wide, all agencies).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24626A0001?
36C24626A0001 (Thyroseq genomic testing) is a 246-Network Contracting Office 6 (36C246) award with an estimated value of —, currently held by Cytopath Biopsy Lab Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C246-26-A-0001?
36C246-26-A-0001 is the dashed form of PIID 36C24626A0001 (Thyroseq genomic testing), held by Cytopath Biopsy Lab Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24626A0001?
246-Network Contracting Office 6 (36C246) awarded 36C24626A0001 to Cytopath Biopsy Lab Inc.
Who is the incumbent on 36C24626A0001?
Cytopath Biopsy Lab Inc is the incumbent with $5.9M across 72 related awards in SCOUT’s public footprint.
When does Cytopath Biopsy Lab Inc’s 36C24626A0001 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.